NYSE Liffe US, the new U.S. futures exchange of NYSE Euronext (NYX), has signed a license agreement with MSCI Inc., a provider of investment decision support tools worldwide, to introduce a package of domestic and international index futures products built on a range of MSCI Equity Indices.
This extensive portfolio of MSCI linked stock index futures will provide broad and efficient market coverage of U.S. and European equity markets, including style and sector exposures as well as coverage of flagship MSCI indices such as the MSCI Emerging Markets (EM), MSCI EAFE, and MSCI BRIC Indices.
These products represent NYSE Liffe US entry into a new asset class beyond the initial gold and silver contracts it opened with in September 2008.
This license agreement marks the beginning of a substantial commitment between two industry leaders in MSCI and NYSE Euronext to develop innovative products serving the needs of the global investment community, says Duncan L. Niederauer, CEO, NYSE Euronext. This exciting set of products fits strategically with NYSE Liffe US evolving value proposition and our commitment to building a premier US futures exchange.
We are very excited by this development. Over the last 40 years MSCI has built a successful franchise and an internationally recognized index brand, says Henry Fernandez, chairman and CEO, MSCI Inc. Our market-leading range of global investable and replicable benchmark indices is now an integral part of the investment processes of thousands of institutional investors around the world. By licensing a global exchange group like NYSE Euronext, many more investors will be able to access the MSCI Equity Indices via the futures marketplace.
In addition to the tremendous liquidity available on the NYSE Arca platform in ETFs based on MSCI indices, and combined with the margin efficiencies available at OCC, the MSCI family of indices are a natural and exciting core product set for NYSE Liffe US, says Thomas F. Callahan, executive vice president, head of U.S. Futures., NYSE Euronext.
Adding futures products based on the MSCI EM and MSCI EAFE Indices to NYSE Liffe US is the first of many innovative futures products that we plan to introduce in the months ahead. NYSE Liffe US delivers credibility and innovation along with the liquidity, functionality and cost effectiveness that our clients demand.
We are delighted to have licensed NYSE Liffe US for the creation of futures contracts based on the MSCI Equity Indices, says David Brierwood, chief operating officer, MSCI Inc., The availability of derivatives based on MSCI indices provides investors around the world with flexible tools to more effectively manage their equity portfolios.
L.D.